Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stroncek

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Oncotarget|April 13, 2016
Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogrammingSilvia Selleri, Panojot Bifsha, Sara Civini, et al.
Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.
JCO Precision Oncology|July 16, 2025
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell TherapyRobert J Kreitman, Brett Schroeder, Evgeny Arons, et al.
JCI Insight|August 16, 2019
Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controllerStephen A Migueles, Cheryl Chairez, Siying Lin, et al.
Microbiome|February 16, 2019
Systemic translocation of Staphylococcus drives autoantibody production in HIV diseaseZhenwu Luo, Min Li, Yongxia Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host DiseaseFrances T Hakim, Sarfraz Memon, Ping Jin, et al.
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Nature Medicine|February 9, 2021
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancersNisha B Nagarsheth, Scott M Norberg, Andrew L Sinkoe, et al.
The Lancet. Neurology|July 24, 2021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot studyIrene Cortese, Erin S Beck, Omar Al-Louzi, et al.
Blood|February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantationDaniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Oncotarget|April 13, 2016
Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogrammingSilvia Selleri, Panojot Bifsha, Sara Civini, et al.
Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.
JCO Precision Oncology|July 16, 2025
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell TherapyRobert J Kreitman, Brett Schroeder, Evgeny Arons, et al.
JCI Insight|August 16, 2019
Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controllerStephen A Migueles, Cheryl Chairez, Siying Lin, et al.
Microbiome|February 16, 2019
Systemic translocation of Staphylococcus drives autoantibody production in HIV diseaseZhenwu Luo, Min Li, Yongxia Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host DiseaseFrances T Hakim, Sarfraz Memon, Ping Jin, et al.
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Nature Medicine|February 9, 2021
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancersNisha B Nagarsheth, Scott M Norberg, Andrew L Sinkoe, et al.
The Lancet. Neurology|July 24, 2021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot studyIrene Cortese, Erin S Beck, Omar Al-Louzi, et al.
Blood|February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantationDaniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Pageof 10